{"id":21787,"date":"2026-01-29T16:49:02","date_gmt":"2026-01-29T07:49:02","guid":{"rendered":"https:\/\/japanir.jp\/en\/ir\/3593-20260129-02_wp_financial_summary\/"},"modified":"2026-01-29T16:49:02","modified_gmt":"2026-01-29T07:49:02","slug":"3593-20260129-02_wp_financial_summary","status":"publish","type":"ir_release","link":"https:\/\/japanir.jp\/en\/company\/company-3593\/ir\/3593-20260129-02_wp_financial_summary\/","title":{"rendered":"Fiscal Year Ending March 2026 Q3 Financial Results Presentation"},"content":{"rendered":"<p>For the cumulative third quarter of the fiscal year ending March 2026, net sales were JPY 28.71 billion (95.7% YoY), operating income was JPY 2.08 billion (61.3% YoY), and net income attributable to owners of parent was JPY 1.43 billion (52.6% YoY), all showing declines.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"3593","jir_company_name":"Hogi Medical Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-01-29","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/01\/3593-20260129-02.pdf","jir_short_summary":"For the cumulative third quarter of the fiscal year ending March 2026, net sales were JPY 28.71 billion (95.7% YoY), operating income was JPY 2.08 billion (61.3% YoY), and net income attributable to owners of parent was JPY 1.43 billion (52.6% YoY), all showing declines.","jir_summary":"### Performance Overview\nFor the cumulative third quarter of the fiscal year ending March 2026, net sales were JPY 28.71 billion, down to 95.7% Year-over-Year. Operating income significantly declined to JPY 2.08 billion (61.3% YoY), and net income attributable to owners of parent dropped sharply to JPY 1.43 billion (52.6% YoY). The cost of sales ratio remained flat at 66.9%, but increased selling, general and administrative expenses along with one-time costs were primary factors in profit reduction. Sales of kit products fell to 96.7% Year-over-Year, and nonwoven fabric product sales continued to face severe conditions. The number of Opera Master contracted facilities increased by 8, reaching 248.\n\n### Business Environment and Strategy\nHospital management has not recovered to pre-COVID-19 levels, and medical service profits are deteriorating. However, discussions on sound management are progressing, triggered by the 2026 medical fee revision. In the medium to long term, hospital function reorganization is advancing, with strong expectations for structural reforms. The sales strategy prioritizes maintaining customer loyalty above all, progressing with sales reforms, product strategy, DX promotion, and procurement reforms. Overseas, a sales company was established in Malaysia to strengthen ASEAN expansion. As part of structural reforms, the company plans to relocate its headquarters in August 2025.","jir_financial_highlights":"Net Sales: JPY 28.71 billion (95.7% Year-over-Year)\nOperating Income: JPY 2.08 billion (61.3% Year-over-Year)\nNet Income Attributable to Owners of Parent: JPY 1.43 billion (52.6% Year-over-Year)\nCost of Sales Ratio: 66.9% (\u25b30.1pt Year-over-Year)\nOperating Income Margin: 7.3% (\u25b34.1pt Year-over-Year)\nNumber of Opera Master Contracted Facilities: 248 facilities (+8 from previous fiscal period) (increase)\nKit Product Sales Composition Ratio: 96.7% (Year-over-Year) (decrease)","jir_category":"","jir_hashtags":"#HogiMedical, #FinancialResultsPresentation, #JapaneseStocks","jir_key_figures":"Net Sales: JPY 28.71 billion (95.7% Year-over-Year)\nOperating Income: JPY 2.08 billion (61.3% Year-over-Year)\nNet Income Attributable to Owners of Parent: JPY 1.43 billion (52.6% Year-over-Year)","jir_meta_title":"Hogi Medical Fiscal Year Ending March 2026 Q3 Financial Results: Net Sales JPY 28.71 Billion, Operating Income JPY 2.08 Billion Decline","jir_meta_description":"Hogi Medical's fiscal year ending March 2026 Q3 financial results. Net sales declined to JPY 28.71 billion (95.7% YoY), operating income to JPY 2.08 billion (61.3% YoY), and net income attributable to owners of parent to JPY 1.43 billion (52.6% YoY). Structural reforms and overseas expansion are ongoing.","jir_og_title":"Hogi Medical Fiscal Year 2026 Q3 Financial Results Announcement","jir_og_description":"Declines in net sales of JPY 28.71 billion, operating income of JPY 2.08 billion, and net income attributable to owners of parent of JPY 1.43 billion. Promoting structural reforms and overseas strategies.","jir_og_image_url":"\/assets\/og\/company-financial_summary.jpg","jir_chart_data_collection":"[{\"jir_chart_id\": \"revenue_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Net Sales Trend (JPY 100 million)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"2024\/03 1Q\\\",\\\"2024\/03 2Q\\\",\\\"2024\/03 3Q\\\",\\\"2024\/03 4Q\\\",\\\"2025\/03 1Q\\\",\\\"2025\/03 2Q\\\",\\\"2025\/03 3Q\\\",\\\"2025\/03 4Q\\\",\\\"2026\/03 1Q\\\",\\\"2026\/03 2Q\\\",\\\"2026\/03 3Q\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Net Sales\\\",\\\"data\\\":[63.39,63.61,66.73,61.28,64.86,65.05,70.02,60.23,63.04,63.76,66.44],\\\"borderColor\\\":\\\"#4caf50\\\",\\\"fill\\\":false}]},\\\"options\\\":{\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"operating_profit_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Operating Income Trend (JPY 100 million)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"2025\/03 1Q\\\",\\\"2025\/03 2Q\\\",\\\"2025\/03 3Q\\\",\\\"2025\/03 4Q\\\",\\\"2026\/03 1Q\\\",\\\"2026\/03 2Q\\\",\\\"2026\/03 3Q\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Operating Income\\\",\\\"data\\\":[12.7,14.9,27.7,20.8,17.2,12.7,20.8],\\\"borderColor\\\":\\\"#2196f3\\\",\\\"fill\\\":false}]},\\\"options\\\":{\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"segment_revenue_breakdown\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Major Product Net Sales (JPY million)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Kit Products\\\",\\\"Nonwoven Fabric\\\",\\\"Mekkin Bag\\\",\\\"New Products\\\",\\\"Other Nonwoven Fabric\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Cumulative Q3 FY2026 Sales Composition Ratio\\\",\\\"data\\\":[6644,1711,1035,944,775],\\\"backgroundColor\\\":[\\\"#4caf50\\\",\\\"#ff9800\\\",\\\"#2196f3\\\",\\\"#9c27b0\\\",\\\"#f44336\\\"]}]},\\\"options\\\":{\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"operamaster_contracts\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Opera Master Contracted Facilities Trend\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"2005\/03\\\",\\\"2010\/03\\\",\\\"2015\/03\\\",\\\"2020\/03\\\",\\\"2025\/03\\\",\\\"2026\/03\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Number of Contracted Facilities\\\",\\\"data\\\":[null,null,null,null,240,248],\\\"borderColor\\\":\\\"#ff5722\\\",\\\"fill\\\":false}]},\\\"options\\\":{\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"profit_increase_decrease_factors\", \"jir_chart_type\": \"waterfall\", \"jir_chart_title\": \"Operating Income Main Increase\/Decrease Factors (JPY million)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Operating Income FY2025\\\",\\\"Sales\/Production Impact\\\",\\\"Cost Ratio Impact\\\",\\\"SG&A Expenses\\\",\\\"Operating Income FY2026\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Amount\\\",\\\"data\\\":[3406,-90,-64,518,-917,2088],\\\"backgroundColor\\\":[\\\"#4caf50\\\",\\\"#f44336\\\",\\\"#f44336\\\",\\\"#2196f3\\\",\\\"#f44336\\\",\\\"#4caf50\\\"]}]},\\\"options\\\":{\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}]","ir_related_company":9238,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-21787","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Fiscal Year Ending March 2026 Q3 Financial Results Presentation - Japan IR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/japanir.jp\/en\/company\/company-3593\/ir\/3593-20260129-02_wp_financial_summary\/\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-3593\/ir\/3593-20260129-02_wp_financial_summary\/\",\"url\":\"https:\/\/japanir.jp\/en\/company\/company-3593\/ir\/3593-20260129-02_wp_financial_summary\/\",\"name\":\"Fiscal Year Ending March 2026 Q3 Financial Results Presentation - Japan IR\",\"isPartOf\":{\"@id\":\"https:\/\/japanir.jp\/en\/#website\"},\"datePublished\":\"2026-01-29T07:49:02+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-3593\/ir\/3593-20260129-02_wp_financial_summary\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/japanir.jp\/en\/company\/company-3593\/ir\/3593-20260129-02_wp_financial_summary\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-3593\/ir\/3593-20260129-02_wp_financial_summary\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/japanir.jp\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Fiscal Year Ending March 2026 Q3 Financial Results Presentation\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/japanir.jp\/en\/#website\",\"url\":\"https:\/\/japanir.jp\/en\/\",\"name\":\"Japan IR\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/japanir.jp\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Fiscal Year Ending March 2026 Q3 Financial Results Presentation - Japan IR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/japanir.jp\/en\/company\/company-3593\/ir\/3593-20260129-02_wp_financial_summary\/","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/japanir.jp\/en\/company\/company-3593\/ir\/3593-20260129-02_wp_financial_summary\/","url":"https:\/\/japanir.jp\/en\/company\/company-3593\/ir\/3593-20260129-02_wp_financial_summary\/","name":"Fiscal Year Ending March 2026 Q3 Financial Results Presentation - Japan IR","isPartOf":{"@id":"https:\/\/japanir.jp\/en\/#website"},"datePublished":"2026-01-29T07:49:02+00:00","breadcrumb":{"@id":"https:\/\/japanir.jp\/en\/company\/company-3593\/ir\/3593-20260129-02_wp_financial_summary\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/japanir.jp\/en\/company\/company-3593\/ir\/3593-20260129-02_wp_financial_summary\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/japanir.jp\/en\/company\/company-3593\/ir\/3593-20260129-02_wp_financial_summary\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/japanir.jp\/en\/"},{"@type":"ListItem","position":2,"name":"Fiscal Year Ending March 2026 Q3 Financial Results Presentation"}]},{"@type":"WebSite","@id":"https:\/\/japanir.jp\/en\/#website","url":"https:\/\/japanir.jp\/en\/","name":"Japan IR","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/japanir.jp\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"related_company_data":{"id":"9238","title":"HOGY MEDICAL CO","ticker":"3593"},"_links":{"self":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/ir-release\/21787","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/ir-release"}],"about":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/types\/ir_release"}],"replies":[{"embeddable":true,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/comments?post=21787"}],"version-history":[{"count":0,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/ir-release\/21787\/revisions"}],"wp:attachment":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/media?parent=21787"}],"wp:term":[{"taxonomy":"sector","embeddable":true,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/sector?post=21787"},{"taxonomy":"importance","embeddable":true,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/importance?post=21787"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}